Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Royal Mail appoints Heathrow executive as new CEO

(Sharecast News) - Royal Mail has appointed a senior executive from Heathrow to become its next boss as parent company International Distribution Services looks to turn its fortunes around. Emma Gilthorpe, the west London airport's chief operating officer since 2020, will join Royal Mail in May, IDS said in a statement on Tuesday.

The job is a new post created under IDS boss Martin Seidenberg. The group's parcels business, GLS, has a separate CEO, Karl Pfaff.

Seidenberg, who took on the Royal Mail job on an interim basis last July, will hold the reins until Gilthorpe joins.

Once in public ownership until the Conservative/LibDem coalition government decided to offload it in 2010, the company has struggled to keep pace with the reduction in letter volumes amid the rise in emails and courier companies grabbing a growing slice of the parcel market.

It has also been criticised for large delays in delivery times for mail and an antagonistic approach to industrial relations, which led to a wave of strikes last year over pay and conditions.

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

Sirius Real Estate ups dividend as profits jump 32%
(Sharecast News) - Profits at business and industrial parks developer Sirius Real Estate surged by nearly a third in the year ended 31 March, helping the company to increase dividends for the tenth straight year.
GSK to appeal Delaware ruling on jury trials in Zantac cancer cases
(Sharecast News) - Pharma giant GSK said it would be appealing against a US court decision allowing jury trials in cases brought by cancer sufferers claiming its heartburn drug caused their condition.
AstraZeneca's lung cancer treatment recommended for approval in EU
(Sharecast News) - AstraZeneca has announced that its Tagrisso treatment for advanced lung cancer, when combined with chemotherapy, has been recommended for approval by European regulators.
China manufacturing PMI ticks up more than expected - Caixin
(Sharecast News) - Activity in China's manufacturing sector grew in May at the fastest rate in two years, according to data released on Monday.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.